Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naĂŻve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8

 

 

 

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Prof. Kang-Ho Choi, Chonnam National University Medical School and Hospital, South Korea

Dr. Kang-ho Choi is an esteemed Associate Professor in the Department of Neurology at Chonnam National University Hospital, Gwangju, Korea. He earned his M.D. from Chonnam National University Medical School in 2005, followed by a Ph.D. from the same institution in 2011. Dr. Choi completed extensive postgraduate training, including fellowships at Hanyang University Medical Center and Bristol University. His research and clinical expertise focus on neurology, with notable contributions in stroke and neurodegenerative diseases. Dr. Choi has received numerous awards for his research and clinical excellence, including multiple “Best Investigator” and “Best Poster Presentation” awards. He is a member of various professional organizations, including the Korean Neurological Association and the American Heart Association/American Stroke Association.

Professional Profile:

Scopus

Evaluation of Kangho Choi, M.D., Ph.D. for the Best Researcher Award

Summary of Suitability for Award:

Dr. Kangho Choi is a distinguished researcher in the field of neurology with an impressive track record of achievements that make him a highly suitable candidate for the Best Researcher Award

🎓Education:

Dr. Kang-ho Choi completed his medical education at Chonnam National University Medical School in Gwangju, Korea, where he earned his M.D. degree from March 1999 to February 2005. He continued his academic journey at Chonnam National University Graduate School, obtaining his Master’s degree (M.S.) from March 2006 to February 2008, and later his Ph.D. from March 2009 to February 2011.

🏢Work Experience:

Dr. Kang-ho Choi has held several key positions in his career. Since November 2016, he has been serving as an Associate Professor in the Department of Neurology at Chonnam National University Hospital in Gwangju, Korea. Prior to this role, he was an Assistant Professor in the same department from March 2011 to October 2016. Dr. Choi completed his Clinical Fellowship at Chonnam National University Hospital from March 2010 to February 2011, and also undertook Research Fellowships at Hanyang University Medical Center in Seoul, Korea, from November 2010 to December 2010, and at the School of Clinical Sciences, Bristol University in the United Kingdom, from March 2013 to June 2013. His foundational training includes a Residency in Neurology at Chonnam National University Hospital from March 2006 to February 2010 and a Medical Internship at the same institution from March 2005 to February 2006.

🏅Awards:

Dr. Kang-ho Choi has received numerous prestigious awards throughout his career, reflecting his significant contributions to neurology. He was honored with the Best Investigator Award from Chonnam National University Hospital in December 2019 and May 2022. Additionally, he received the Break-through of the Year award from KHIDI of Korea in December 2017 and from the NRF of Korea in December 2020. In July 2017, he earned the Young Investigator Award at the Hwasun Biomedical Workshop. Dr. Choi’s excellence in research presentations is highlighted by multiple Best Poster Presentation Awards, including those from the ICSU & ICAS Joint Conference in September 2016, the ICSU 2018 & 1st AKJSC Joint Conference in September 2018, Stroke Update 2023 & 11th JKJSC in November 2023, and APSC 2023 in December 2023. His accolades also include the Best Presentation Award at the 35th Conference of KNA in November 2016, the Best Article award at the Annual Meeting of the Korean Neurological Association in October 2009, and the Best Doctor of the Year award from Chonnam National University Hospital in February 2010. Earlier in his career, he was recognized as the Best Resident of the Year by The Korean Intern Resident Association in February 2007.

Publication Top Notes:

  • Focused Magnetic Stimulation for Motor Recovery After Stroke
  • Treatment of Ischemic Stroke by Atorvastatin-Loaded PEGylated Liposome
  • Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke
  • Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
  • Erratum: Corrigendum to “D-dimer to Fibrinogen Ratio Predicts Early Neurological Deterioration in Ischemic Stroke with Atrial Fibrillation”